|
Aug 29
|
BioInvent International AB: Interim Report January-June 2024
|
|
Aug 28
|
Exploring 3 High Growth Tech Stocks in Sweden
|
|
Jul 30
|
BioInvent Receives Notice of Allowance from USPTO for BI-1910 Patent Application
|
|
Jun 24
|
BioInvent Gains Patent for BI-1808 in China
|
|
Jan 12
|
BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis
|
|
Dec 5
|
BioInvent Presents Positive First Clinical Data on Anti-FcyRIIB Antibody BI-1607
|
|
Dec 5
|
BioInvent Enrolls First Patient in Phase 1/2a Clinical Trial with TNFR2 Antibody BI-1910
|
|
Sep 27
|
BioInvent to Hold Two Poster Presentations at SITC 38th Annual Meeting
|